logo
Select company
Select metric
-18.85%EBIT Margin
VS
Market
23
Sector
56
Industry
78
History
92
$ 0.54Close
$ 0.39 - $ 1.72 52-Week Range
Ticker Information

Ticker

IPSC

Company Name

CENTURY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CENTURY THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IPSC - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -21.51M-18.85%$ 114.13M
3/31/2025$ -20.16M-17.54%$ 114.9M
12/31/2024$ -124.78M-1893.7%$ 6.59M
9/30/2024$ -130.75M-4869.53%$ 2.69M
6/30/2024$ -131.64M-6446.67%$ 2.04M
3/31/2024$ -132.66M-9683.28%$ 1.37M
12/31/2023$ -134.25M-6006.8%$ 2.23M
9/30/2023$ -125.22M-5033.04%$ 2.49M
6/30/2023$ -123.44M-2704.75%$ 4.56M
3/31/2023$ -121.88M-2079.51%$ 5.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CENTURY THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, CENTURY THERAPEUTICS INC's average EBIT % has been -4258.81%.
  • The median EBIT % for CENTURY THERAPEUTICS INC during this period was -3787.14%
  • CENTURY THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -17.54%.
  • The lowest EBIT % recorded by CENTURY THERAPEUTICS INC in the same timeframe -10742.44%

CENTURY THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
STRO : SUTRO BIOPHARMA INC -174.93%KPTI : KARYOPHARM THERAPEUTICS INC -57.38%FBIO : FORTRESS BIOTECH INC -0.34%IGMS : IGM BIOSCIENCES INC -36.8%VERU : VERU INC -482.04%MRSN : MERSANA THERAPEUTICS INC -202.14%ADAP : ADAPTIMMUNE THERAPEUTICS PLC -246.42%XCUR : EXICURE INC -ATNM : ACTINIUM PHARMACEUTICALS INC -ALGS : ALIGOS THERAPEUTICS INC -1936.36%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for CENTURY THERAPEUTICS INC is calculated as follows: EBIT [ $ -53.19M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

IPSC - EBIT Margin, Last 5 years

-10742.44%

Minimum

Mar 31, 2022

-17.54%

Maximum

Mar 31, 2025

-4258.81%

Average

-3787.14%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%